Lion Biotechnologies Inc (LBIO)

7.10
0.15 2.20
NASDAQ : Health Care
Prev Close 6.95
Open 7.00
Day Low/High 6.90 / 7.15
52 Wk Low/High 4.24 / 10.15
Volume 58.56K
Avg Volume 237.10K
Exchange NASDAQ
Shares Outstanding 62.31M
Market Cap 414.37M
EPS -3.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

LBIO LOSS NOTICE: Rosen Law Firm Reminds Lion Biotechnologies, Inc. Investors Of Important First Filed Class Action - LBIO

LBIO LOSS NOTICE: Rosen Law Firm Reminds Lion Biotechnologies, Inc. Investors Of Important First Filed Class Action - LBIO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lion Biotechnologies, Inc.

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Lion Biotechnologies, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Lion Biotechnologies, Inc.

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Lion Biotechnologies, Inc.

Rosen Law Firm, a global investor rights law firm, announces that it has filed a class action lawsuit on behalf of purchasers of Lion Biotechnologies, Inc.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Lion Biotechnologies, Inc. Investors

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Lion Biotechnologies, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Lion Biotechnologies, Inc.

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

INVESTOR ALERT: Khang & Khang LLP Announces An Investigation Of Lion Biotechnologies, Inc. And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Lion Biotechnologies, Inc.

Notable Wednesday Option Activity: LBIO, STMP, ZIOP

Notable Wednesday Option Activity: LBIO, STMP, ZIOP

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lion Biotechnologies Inc , where a total of 2,000 contracts have traded so far, representing approximately 200,000 underlying shares. That amounts to about 69.5% of LBIO's average daily trading volume over the past month of 287,740 shares.

INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of Lion Biotechnologies, Inc. Investors

INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of Lion Biotechnologies, Inc. Investors

Law Offices of Howard G. Smith announces an investigation on behalf of investors of Lion Biotechnologies, Inc.

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces An Investigation Of Lion Biotechnologies, Inc. And Advises Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces An Investigation Of Lion Biotechnologies, Inc. And Advises Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Lion Biotechnologies, Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Lion Biotechnologies, Inc. - LBIO

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Lion Biotechnologies, Inc. - LBIO

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Lion Biotechnologies, Inc.

First Week of May 19th Options Trading For Lion Biotechnologies (LBIO)

First Week of May 19th Options Trading For Lion Biotechnologies (LBIO)

Investors in Lion Biotechnologies Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the LBIO options chain for the new May 19th contracts and identified the following call contract of particular interest.

Short Interest Moves 15% Lower For LBIO

Short Interest Moves 15% Lower For LBIO

The most recent short interest data has been released for the 03/15/2017 settlement date, which shows a 732,082 share decrease in total short interest for Lion Biotechnologies Inc , to 4,153,637, a decrease of 14.98% since 02/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

These 5 Stocks Under $10 Could Ignite Soon

These 5 Stocks Under $10 Could Ignite Soon

Here's a technical look at how to trade several under-$10 stocks that could break out soon.

Commit To Buy Lion Biotechnologies At $5, Earn 14.9% Annualized Using Options

Commit To Buy Lion Biotechnologies At $5, Earn 14.9% Annualized Using Options

Investors eyeing a purchase of Lion Biotechnologies Inc stock, but cautious about paying the going market price of $7.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $5 strike, which has a bid at the time of this writing of 30 cents.

Commit To Purchase Lion Biotechnologies At $5, Earn 13.5% Annualized Using Options

Commit To Purchase Lion Biotechnologies At $5, Earn 13.5% Annualized Using Options

Investors eyeing a purchase of Lion Biotechnologies Inc shares, but tentative about paying the going market price of $8.30/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $5 strike, which has a bid at the time of this writing of 30 cents.

Lion Biotechnologies: Is This Tiny Biotech Company Ready to Roar?

Lion Biotechnologies: Is This Tiny Biotech Company Ready to Roar?

Analysts are calling for shares in this small immunotherapy developer to nearly double in the next 12 months. But with no profit or revenue, is it a safe bet?

Here's Why Lion Biotechnologies (LBIO) Stock Is Spiking Today

Here's Why Lion Biotechnologies (LBIO) Stock Is Spiking Today

Lion Biotechnologies (LBIO) stock is skyrocketing after naming a new CEO and announcing a private offering.

Notable Friday Option Activity: LBIO, ASC, PODD

Notable Friday Option Activity: LBIO, ASC, PODD

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Lion Biotechnologies Inc , where a total volume of 11,395 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 707.3% of LBIO's average daily trading volume over the past month, of 161,115 shares.